Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · Real-Time Price · USD
1.480
-0.020 (-1.33%)
Nov 4, 2024, 4:00 PM EST - Market closed
Oncternal Therapeutics Employees
As of December 31, 2023, Oncternal Therapeutics had 30 total employees, including 27 full-time and 3 part-time employees. The number of employees decreased by 3 or -9.09% compared to the previous year.
Employees
30
Change (1Y)
-3
Growth (1Y)
-9.09%
Revenue / Employee
$61,533
Profits / Employee
-$1,199,100
Market Cap
4.38M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Pharma Holdings | 231 |
Fresh2 Group | 75 |
Theriva Biologics | 22 |
Pasithea Therapeutics | 8 |
Enveric Biosciences | 7 |
Synaptogenix | 5 |
Lixte Biotechnology Holdings | 4 |
180 Life Sciences | 4 |
ONCT News
- 3 months ago - Oncternal Therapeutics, Inc. (ONCT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Oncternal Therapeutics to Present in JonesTrading Healthcare Summit - GlobeNewsWire
- 5 months ago - Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer - GlobeNewsWire
- 6 months ago - Oncternal Therapeutics, Inc. (ONCT) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results - GlobeNewsWire